Cargando…

Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target

Pancreatic cancer is a lethal solid malignancy with limited therapeutic options. The development of novel therapeutic drugs requires adequate new cell line models. A new pancreatic cancer cell line, designated PDXPC1, was established from one pancreatic ductal adenocarcinoma (PDAC) patient-derived x...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xiaoxiao, He, Kuifeng, Huang, Yingying, Xu, Zhenzhen, Kong, Mei, Zhang, Jing, Cao, Jiang, Teng, Lisong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010221/ https://www.ncbi.nlm.nih.gov/pubmed/32124956 http://dx.doi.org/10.3892/ijo.2020.4965

Ejemplares similares

COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2019)

Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend
por: Zhang, Jing, et al.
Publicado: (2020)

Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways
por: Wang, Haiyong, et al.
Publicado: (2017)

Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines
por: Ma, Yixuan, et al.
Publicado: (2022)

What is the origin of pancreatic adenocarcinoma?
por: Pour, Parviz M, et al.
Publicado: (2003)

The Essential Factors of Establishing Patient-derived Tumor Model
por: Chen, Chuanzhi, et al.
Publicado: (2021)

MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines
por: Dandrea, Mario, et al.
Publicado: (2009)

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
por: He, Kuifeng, et al.
Publicado: (2012)

LncRNA UCA1 in anti-cancer drug resistance
por: Wang, Haohao, et al.
Publicado: (2017)

Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition
por: Brannon, Arthur, et al.
Publicado: (2020)

MEK5 promotes lung adenocarcinoma
por: Sánchez-Fdez, Adrián, et al.
Publicado: (2019)

Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers
por: Hirsch, Daniela, et al.
Publicado: (2020)

Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary
por: Yamada, Takashi, et al.
Publicado: (2013)

Establishment and Validation of a Ferroptosis-Related Long Non-Coding RNA Signature for Predicting the Prognosis of Stomach Adenocarcinoma
por: Zhang, Shuqiong, et al.
Publicado: (2022)

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung
por: Kalinina, Tatyana, et al.
Publicado: (2010)

Giant appendiceal neurofibroma in von Recklinghausen’s disease: A case report and literature review
por: GUO, LIWEN, et al.
Publicado: (2014)

Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS(G12R)-mutant pancreatic ductal adenocarcinoma
por: Kenney, Cara, et al.
Publicado: (2021)

Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer
por: Gu, Yu, et al.
Publicado: (2016)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

Infrequent Mutation of Lysophosphatidic Acid Receptor-1 Gene in Hamster Pancreatic Duct Adenocarcinomas and Established Cell Lines
por: Tsujiuchi, Toshifumi, et al.
Publicado: (2009)

MiR-301a-5p/SCIN promotes gastric cancer progression via regulating STAT3 and NF-κB signaling
por: Huang, Yingying, et al.
Publicado: (2021)

EGF suppresses the expression of miR-124a in pancreatic β cell lines via ETS2 activation through the MEK and PI3K signaling pathways
por: Yang, Lin, et al.
Publicado: (2019)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

Production of plasminogen activator by established cell lines of mouse origin
Publicado: (1977)

Establishment and characterisation of six human colorectal adenocarcinoma cell lines.
por: Kirkland, S. C., et al.
Publicado: (1986)

Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response
por: Braun, Rüdiger, et al.
Publicado: (2023)

Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases
por: Jin, Ketao, et al.
Publicado: (2011)

Establishment of a first-line second-line treatment model for human pulmonary adenocarcinoma
por: Wang, Lining, et al.
Publicado: (2016)

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
por: Jiang, Haiping, et al.
Publicado: (2022)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

A Pro-Endocrine Pancreatic Islet Transcriptional Program Established During Development Is Retained in Human Gallbladder Epithelial Cells
por: Joglekar, Mugdha V., et al.
Publicado: (2022)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

DNA replication origins retain mobile licensing proteins
por: Sánchez, Humberto, et al.
Publicado: (2021)

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
por: Nicolle, Rémy, et al.
Publicado: (2020)

Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy
por: Estep, Anne L., et al.
Publicado: (2007)

Analysis of lncRNA–mRNA networks after MEK1/2 inhibition based on WGCNA in pancreatic ductal adenocarcinoma
por: Qian, Jing, et al.
Publicado: (2019)

ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway
por: Wen, Xin, et al.
Publicado: (2022)

KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition
por: Hamidi, H, et al.
Publicado: (2014)

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
por: Ghosn, Marwan, et al.
Publicado: (2016)

Pancreatic adenocarcinoma: Beyond first line, where are we?
por: Cherri, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3cqpipeovla98hm1veksmujf6c